Skip to content

Safety and efficacy of ciprofol for the sedation/anesthesia in pediatric fiber bronchoscope

Safety and efficacy of ciprofol for the sedation/anesthesia in pediatric fiber bronchoscope

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072732
Enrollment
Unknown
Registered
2023-06-23
Start date
2023-06-15
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Group C1:The patient received 0.4mg/kg ciprofol for anesthesia induction and maintenance
Group C2:The patient received 0.4mg/kg ciprofol for anesthesia induction and maintenance
Group P:The patient received 2.0mg/kg propofol for anesthesia induction and maintenance

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1) ASA?~? grade 2) Children who plan to receive elective tracheoscopy 3) Age range from 1 to 10 years 4) BMI18~28kg/m2.

Exclusion criteria

Exclusion criteria: 1) Patients with a history of anaesthetic drug allergy 2) Congenital heart disease (tetralogy of Fallot, patent ductus arteriosus, ventricular septal defect, pulmonary hypertension) 3) People with severe neurological and mental diseases and cognitive dysfunction 4) Patients with perioperative experience of general anesthesia within 4 weeks.

Design outcomes

Primary

MeasureTime frame
Sedation success rate;

Secondary

MeasureTime frame
Injection pain;Blood pressure;Heart rate;SpO2;

Countries

China

Contacts

Public ContactZhong Yu

The First Affiliated Hospital of Guangxi Medical University

zzlugl@163.com+86 151 7792 9679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026